Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Ethicon Sarl: medical device reports filed with FDA

1,739 reports name it as the manufacturer of the device involved, 2013–2017.

1,739
reports naming it as manufacturer
0% of all MAUDE reports
0
reports, 12 months to August 2026
0 in the 12 months before
1.4%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

1,739 medical device reports received by FDA give Ethicon Sarl as the manufacturer of the device involved, 0% of the MAUDE database, from June 2013 to August 2017. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.6%) and malfunction (1.4%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Gynecare Tvt Retropubic SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator57400%
Gynecare Tvt Obturator SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator48900%
Gynecare TVTMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator12530%
Gynecare Tvt Exact Continence SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator10300%
Gynecare Tvt Secur SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, female, mini-sling9200%
Gynecare Tvt-Aa AbdominalMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator7500%
Gynecare Tvt Abrevo Continence SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator6300%
Gynecare Tvt Oburator SystemMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator5300.1%
Gynecare Prolift Total Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed4700.1%
Gynecare Prolift Anterior Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed2100%
Gynecare Prolift Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed1900%
Gynecare Prolift +m Total Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed1400%
Gynecare Prolift Posterior Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed1000%
Gynecare Prosima Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed900%
Gynecare Prolift +m Anterior Pelvic Floor Repair SystemMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed700%
Surgicel Absorbable HemostatAgent, absorbable hemostatic, collagen based302.1%
Gynecare Mesh UnknownMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator130.1%
Gynecare Tvt Obturator W LasrMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator1140%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
OTNMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator1,48785.5%
OTPMesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed1538.8%
PAHMesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, female, mini-sling925.3%
LMFAgent, absorbable hemostatic, collagen based60.3%
FTLMesh, surgical, polymeric10.1%
OTOMesh, surgical, synthetic, urogynecologic, for apical vaginal and uterine prolapse, transabdominally placed10.1%

Reports by month, five years

011Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0%0
Injury98.6%1,714
Malfunction1.4%25
Other0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Ethicon Sarl reports

How many FDA device reports name Ethicon Sarl as manufacturer?

1,739 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Gynecare Tvt Retropubic System (574), Gynecare Tvt Obturator System (489), Gynecare TVT (125), Gynecare Tvt Exact Continence System (103) and Gynecare Tvt Secur System (92).

Which device types does it report on?

mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator (85.5%), mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed (8.8%), mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, female, mini-sling (5.3%) and agent, absorbable hemostatic, collagen based (0.3%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.